Your Health, We Care
selpercatinib is indicated for the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement as detected by an FDA-approved test.
selpercatinib is indicated for the treatment of adults with relapsed or refractory myeloid/lymphoid neoplasms (MLNs) with fibroblast growth factor receptor 1 (FGFR1)rearrangement.
from FDA，2024.06
Serpatinib is a new type of therapeutic drug that has attracted much attention in recent years. Its unique pharmacological effects and wide range of indications make it an importan···【more】
Article source：Lucius LaosRelease date：2024-12-24Recommended：124
Serpatinib is an innovative drug that is attracting increasing attention for its application in the treatment of specific diseases. This article will provide an in-depth discussion···【more】
Article source：Lucius LaosRelease date：2024-12-24Recommended：105
Serpatinib, a new type of drug, is increasingly used in the medical field. Its indications, side effects, and treatment measures for specific side effects have become the focus of ···【more】
Article source：Lucius LaosRelease date：2024-12-23Recommended：117
Selpercatinib is a targeted therapy drug that is mainly used to inhibit cancer caused by mutations in the RET gene. It has shown remarkable efficacy in controlling the spread of ca···【more】
Article source：Lucius LaosRelease date：2024-08-15Recommended：141
As a targeted drug targeting RET mutations, Selpercatinib can block the signaling pathway of tumors, and has performed well in the treatment of advanced or metastatic cancers, maki···【more】
Article source：Lucius LaosRelease date：2024-08-15Recommended：121
Serpatinib interferes with the growth signal of cancer cells by selectively inhibiting RET kinase. It is suitable for a variety of RET gene-related cancer types, such as medullary ···【more】
Article source：Lucius LaosRelease date：2024-08-15Recommended：157
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
